Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice. 2003

Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
Division of Cellular Immunology, Tumor Immunology Program, German Cancer Research Center, Heidelberg, Germany. P.Beckhove2dkfz-heidelberg.de

We describe a new human tumor xenotransplant animal model that is highly efficient for engraftment, does not need host conditioning and is suitable for in vivo studies of human tumors. Pieces of 61 freshly operated primary breast tumors were implanted into 172 irradiated and 228 nonconditioned NOD/Scid mice. A high mortality was observed in irradiated but not in nonconditioned recipients. More than 90% of analyzed implanted breast cancer specimens engrafted in the NOD/Scid mice irrespective of pretreatment. The tumors were vascularized within 3 days of implantation and maintained original histomorphology as well as expression patterns of tumor markers (cytokeratin and MUC1) and cytokines (tumor necrosis factor alpha (TNF-alpha), interleukin-4 (IL-4) and IL-10) released by adjacent stromal cells. A majority of tumors grew slowly, locally infiltrating host tissue, whereas some grew aggressively, developing large, fatal tumor masses and metastases within regional lymph nodes. Tumor progression in mice correlated with stage, grade, proliferation index and hormone receptor status of primary tumors. The reproducible growth behavior and preservation of characteristic features suggest that this new xenotransplant model is relevant and can be recommended for testing new anticancer therapies.

UI MeSH Term Description Entries
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D016246 Lymphocytes, Tumor-Infiltrating Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer. Tumor Infiltrating Lymphocyte,Tumor-Derived Activated Cell,Tumor-Derived Activated Cells,Tumor-Infiltrating Lymphocyte,Tumor-Infiltrating Lymphocytes,Activated Cell, Tumor-Derived,Activated Cells, Tumor-Derived,Infiltrating Lymphocyte, Tumor,Infiltrating Lymphocytes, Tumor,Lymphocyte, Tumor Infiltrating,Lymphocyte, Tumor-Infiltrating,Lymphocytes, Tumor Infiltrating,Tumor Derived Activated Cell,Tumor Derived Activated Cells,Tumor Infiltrating Lymphocytes

Related Publications

Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
January 2009, Stem cells (Dayton, Ohio),
Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
August 2005, Leukemia,
Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
April 1995, The American journal of pathology,
Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
February 2006, Clinical and vaccine immunology : CVI,
Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
April 2019, Aesthetic plastic surgery,
Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
September 2002, Leukemia,
Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
October 2006, Haematologica,
Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
May 2000, Blood,
Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
December 2005, European journal of immunology,
Philipp Beckhove, and Florian Schütz, and Ingo J Diel, and Erich-Franz Solomayer, and Gunther Bastert, and Joanna Foerster, and Markus Feuerer, and Lianhua Bai, and Hans-Peter Sinn, and Viktor Umansky, and Volker Schirrmacher
August 2012, Cell death & disease,
Copied contents to your clipboard!